Prostate Cancer Test Deal Forged by Minomic, Cirrus Dx

Jun

Lowering RNA-seq Costs via Enzymatic rRNA Depletion with Custom, Species-specific Probes

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type.

Jun

Personal and Clinical Utility of Polygenic Risk Scores: A Review of the Evidence

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Jun

Featured Webinar

Menu

Prostate Cancer Test Deal Forged by Minomic, Cirrus Dx

To read the full story....

Breaking News

FDA Clears InBios International Zika Antibody Test

Beckman Coulter Life Sciences Recalls Hematology Analyzers Due to Risk of Inaccurate Results

Qiagen-Backed Firm Apis Assay Technologies Launches in Manchester Innovation Hub

FDA Clears Automated Culture Screening, Interpretation System

Roche Obtains FDA Clearance for Sexually Transmitted Disease Test

FDA Clears Cepheid, Hologic CT/NG Assays for Extragenital Testing

Lowering RNA-seq Costs via Enzymatic rRNA Depletion with Custom, Species-specific Probes

Personal and Clinical Utility of Polygenic Risk Scores: A Review of the Evidence

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

What's Popular?

Guardant Health Prices $319.5M Public Stock Offering

Beckman Coulter Life Sciences Recalls Hematology Analyzers Due to Risk of Inaccurate Results

Guardant Health Plans Public Offering of 4.5M Shares

Biocept Targets Pathologists, Naturopaths to Drive Liquid Biopsy Adoption

Biocept Shares Skyrocket on Commercial Launch of Lung Cancer Liquid Biopsy Test

Sponsorships